Arteris, Inc. (NASDAQ:AIP - Get Free Report) VP Paul L. Alpern sold 2,471 shares of the company's stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $11.41, for a total value of $28,194.11. Following the sale, the vice president now owns 64,930 shares in the company, valued at $740,851.30. The trade was a 3.67 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.
Arteris Stock Performance
Shares of NASDAQ AIP traded up $0.03 during mid-day trading on Monday, reaching $12.28. 495,407 shares of the company were exchanged, compared to its average volume of 869,555. Arteris, Inc. has a twelve month low of $4.83 and a twelve month high of $12.64. The stock has a market capitalization of $493.37 million, a P/E ratio of -12.79 and a beta of 1.17. The company's 50-day simple moving average is $9.00 and its 200-day simple moving average is $8.08. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30.
Wall Street Analysts Forecast Growth
Separately, Rosenblatt Securities reiterated a "buy" rating and set a $15.00 price objective on shares of Arteris in a research note on Wednesday, November 6th.
Read Our Latest Stock Analysis on AIP
Hedge Funds Weigh In On Arteris
Several institutional investors and hedge funds have recently made changes to their positions in the company. Bank of New York Mellon Corp bought a new stake in Arteris in the 2nd quarter valued at $580,000. Rhumbline Advisers grew its stake in shares of Arteris by 2,182.8% in the second quarter. Rhumbline Advisers now owns 31,822 shares of the company's stock valued at $239,000 after acquiring an additional 30,428 shares in the last quarter. Renaissance Technologies LLC grew its stake in shares of Arteris by 6.1% in the second quarter. Renaissance Technologies LLC now owns 114,700 shares of the company's stock valued at $861,000 after acquiring an additional 6,600 shares in the last quarter. CloudAlpha Capital Management Limited Hong Kong bought a new position in Arteris during the second quarter worth about $554,000. Finally, The Manufacturers Life Insurance Company acquired a new stake in Arteris in the 2nd quarter worth about $86,000. Institutional investors and hedge funds own 64.36% of the company's stock.
Arteris Company Profile
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.